Tag: CBT > CBD Medical Cannabis Research

CBD Industry

Judge Denies SAM’s Temporary Restraining Order; CBD Pilot Program Launches

The judge set an April 20 hearing date for Smart Approaches to Marijuana’s lawsuit attempting to stop the Centers for Medicare and Medicaid Services’ program.

April 1, 2026

CBD Industry

High Tide Subsidiary NuLeaf Naturals Pursues Participation in US Medicare CBD Pilot Program

NuLeaf Naturals is well-positioned to serve as a supplier to participating organizations under the CMS Innovation Center’s Beneficiary Engagement Incentive.

April 1, 2026

CBD Industry

Vlasic Labs CBD Products Qualify for CMS Pilot Program

The company’s product line is eligible for the Centers for Medicare and Medicaid Services’ program for hemp-derived cannabidiol products.

March 31, 2026

Colorado

First-of-its-Kind Medical-Grade Cannabis Pharmacy Launches in Colorado

Kazmira Pharmacy is the first licensed 503A compounding pharmacy in the country offering THC-free, prescription-only CBD.

January 20, 2026

Cannabis Industry Research

CannaLean Biotechs Completes First-in-Human Feasibility Study of Its Novel CBD-Based, Lipid-Lowering Therapy

The company’s study has demonstrated positive results in adults with elevated LDL cholesterol.

January 20, 2026

Industry Headlines

Tilray Medical Publishes Pioneering Research on Pharmacokinetics of THC, CBD Formulations

The new study provides insight into the bioavailability of medical cannabis formulations for therapeutic treatment.

June 26, 2025

Industry Headlines

DeFloria Receives Investigational New Drug Application Clearance From FDA for Cannabinoid Drug to Treat Autism Spectrum Disorder

DeFloria plans to initiate a Phase 2 clinical trial by mid-year 2025.

February 24, 2025

Industry Headlines

Jazz Pharmaceuticals Showcases Evidence Reinforcing Epidiolex (CBD) Medical Benefits

The pharmaceutical company presented data for cannabis-based medicine’s broad-spectrum efficacy in treatment-resistant epilepsies.

December 10, 2024

Cannabis Industry Research

Medical Marijuana Act Signed by Biden Would Hinder Research Under Rescheduling

The Medical Marijuana and Cannabidiol Research Expansion Act’s requirements would remain under Schedule III, a congressional researcher says.

September 20, 2024

Top Stories

Lawmakers 'Deeply Concerned' About Medical Cannabis Act's Implementation

Congressmen Earl Blumenauer and Andy Harris sent a letter requesting answers from the DEA and HHS on barriers to cannabis research and the government agencies’ missed report deadline that is required by the Medical Marijuana and Cannabidiol Research Expansion Act.

March 12, 2024

Cannabis Price Compression

Cannabis Conference to Feature Home Grow, Medical Cannabis Research Education

These groundbreaking sessions will dive into the realms of personal cultivation and the cutting edge of medical cannabis research.

August 2, 2023

Legislation and Regulation

UPDATED: President Biden Signs Bipartisan Cannabis Research Bill

The legislation cleared its final congressional hurdle with a voice vote last month in the Senate, paving way for researchers to fully study the impacts of cannabis use.

December 2, 2022